Ute Ganswindt
Overview
Explore the profile of Ute Ganswindt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
160
Citations
2837
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nagler F, Vorbach S, Mohamed A, Thaqi S, Thaqi S, Adebahr S, et al.
Int J Radiat Oncol Biol Phys
. 2025 Jan;
PMID: 39761798
Purpose: The value of stereotactic body radiation therapy (SBRT) in patients with oligometastatic head-and-neck squamous cell carcinoma (HNSCC) remains unclear, as existing evidence is primarily derived from retrospective single-center analyses...
2.
Vorbach S, Pointner M, Lehmann J, Mangesius J, Hart T, Gstir C, et al.
Cancers (Basel)
. 2024 Oct;
16(20).
PMID: 39456646
Background/objectives: Informed consent is crucial in medical practice, especially for complex treatments such as postoperative radiotherapy for patients with breast cancer. Conventional consent procedures are often based on verbal declarations...
3.
Vorbach S, Seppi T, Sarcletti M, Kollotzek S, Mangesius J, Lehmann J, et al.
Head Neck
. 2024 Aug;
47(1):242-253.
PMID: 39114975
Background: We report on the characterization and introduction of a novel prognostic score for patients undergoing stereotactic body radiotherapy (SBRT) for the treatment of single and multiple pulmonary metastases (PMs)...
4.
Arnold C, Mangesius J, Portnaia I, Ganswindt U, Wolff H
Front Oncol
. 2024 Jun;
14:1379986.
PMID: 38873260
Despite a comparatively favorable prognosis relative to other malignancies, breast cancer continues to significantly impact women's health globally, partly due to its high incidence rate. A critical factor in treatment...
5.
Danko B, Hess J, Unger K, Samaga D, Walz C, Walch A, et al.
NPJ Precis Oncol
. 2024 May;
8(1):116.
PMID: 38783045
Head and Neck Squamous Cell Carcinoma (HNSCC) is a heterogeneous malignancy that remains a significant challenge in clinical management due to frequent treatment failures and pronounced therapy resistance. While metabolic...
6.
Mangesius J, Seppi T, Arnold C, Mangesius S, Kerschbaumer J, Demetz M, et al.
Curr Oncol
. 2024 Apr;
31(4):1739-1751.
PMID: 38668035
This study aims to evaluate the clinical outcome of stereotactic radiosurgery as the sole treatment for brain metastases and to assess prognostic factors influencing survival. A total of 108 consecutive...
7.
Linge A, Patil S, Grosser M, Lohaus F, Gurtner K, Kemper M, et al.
Radiother Oncol
. 2023 Dec;
191:110055.
PMID: 38109944
Purpose: To assess the robustness of prognostic biomarkers and molecular tumour subtypes developed for patients with head and neck squamous cell carcinoma (HNSCC) on cell-line derived HNSCC xenograft models, and...
8.
Vorbach S, Mangesius J, Dejaco D, Seppi T, Santer M, Zur Nedden S, et al.
Cancers (Basel)
. 2023 Nov;
15(21).
PMID: 37958426
Current literature regarding survival and treatment outcome of SBRT in patients with pulmonary oligometastatic head and neck squamous cell carcinoma (HNSCC) is limited. Additionally, most of the published studies include...
9.
Starke S, Zwanenburg A, Leger K, Lohaus F, Linge A, Kalinauskaite G, et al.
Cancers (Basel)
. 2023 Oct;
15(19).
PMID: 37835591
Neural-network-based outcome predictions may enable further treatment personalization of patients with head and neck cancer. The development of neural networks can prove challenging when a limited number of cases is...
10.
Mangesius J, Seppi T, Ibrahim R, Fleischmann K, Ginestet A, Vorbach S, et al.
Phys Eng Sci Med
. 2023 Jul;
46(4):1365-1374.
PMID: 37523057
Introduction: Recent advances in the radiation therapy of prostate cancer have brought a shift toward moderate- and ultra-hypofractionated treatment schedules. Reducing safety margins can broaden the therapeutic window in stereotactic...